Detalles de la búsqueda
1.
Correlation between IPSET-t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience.
Ann Hematol
; 103(2): 443-448, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38072850
2.
Correction to: Correlation between IPSETt risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience.
Ann Hematol
; 103(2): 449, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38157002
3.
Flai (fludarabine, cytarabine, idarubicin) plus low-dose Gemtuzumab Ozogamicin as induction therapy in CD33-positive AML: Final results and long term outcome of a phase II multicenter clinical trial.
Am J Hematol
; 93(5): 655-663, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29396857
4.
ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML.
Eur J Haematol
; 99(3): 269-274, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28618016
5.
Multicentre survey to explore current survival of patients with acute myeloid leukaemia who failed induction chemotherapy.
Eur J Haematol
; 96(6): 586-92, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26186084
6.
Complete and long-lasting cytologic and molecular remission of FIP1L1-PDGFRA-positive acute eosinophil myeloid leukaemia, treated with low-dose imatinib monotherapy.
Eur J Haematol
; 92(6): 541-5, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24460680
7.
Antifungal prophylaxis with posaconazole in patients with acute myeloid leukemia: dose intensification coupled with avoidance of proton pump inhibitors is beneficial in shortening time to effective concentrations.
Antimicrob Agents Chemother
; 57(12): 6081-4, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24060872
8.
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients.
Am J Hematol
; 88(10): 848-52, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23760853
9.
Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia.
Ann Hematol
; 91(12): 1937-43, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22893485
10.
Monitoring of minimal residual disease by quantitative WT1 gene expression following reduced intensity conditioning allogeneic stem cell transplantation in acute myeloid leukemia.
Clin Transplant
; 25(2): 308-16, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-20412098
11.
BCL-2 Expression in AML Patients over 65 Years: Impact on Outcomes across Different Therapeutic Strategies.
J Clin Med
; 10(21)2021 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34768616
12.
Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) relapsing after allogeneic stem cell transplantation and resistant to imatinib.
Leuk Res
; 33(1): 174-7, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18471874
13.
Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia.
Eur J Haematol
; 82(1): 61-8, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18801058
14.
Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years.
Leuk Res
; 32(12): 1800-8, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18621416
15.
High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients.
Leuk Res
; 58: 31-38, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28407515
16.
Predictive value of pretransplantation molecular minimal residual disease assessment by WT1 gene expression in FLT3-positive acute myeloid leukemia.
Exp Hematol
; 49: 25-33, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28159598
17.
Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey.
Leuk Res
; 53: 74-81, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28056398
18.
Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors.
Oncotarget
; 6(30): 30212-21, 2015 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26338961
19.
FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience.
Am J Hematol
; 84(10): 690-2, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19731308
20.
Extramedullary progression of multiple myeloma under thalidomide therapy despite concomitant response of medullary disease.
Am J Hematol
; 83(8): 680-1, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18459108